2022 年，在观察到 COVID-19 大流行期间社区抗生素消耗下降后，欧盟/欧洲经济区出现反弹。
Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022.
机构信息
European Centre for Disease Prevention and Control, Solna, Sweden.
Clinical Hospital Center Rijeka and University of Rijeka Medical Faculty, Rijeka, Croatia.
出版信息
Euro Surveill. 2023 Nov;28(46). doi: 10.2807/1560-7917.ES.2023.28.46.2300604.
We observed a rebound in consumption of antibacterials for systemic use (ATC J01) in the community sector in the European Union/European Economic Area during 2021 and 2022, after an observed decrease between 2019 and 2020. The rates in 2022 returned to pre-COVID-19-pandemic levels and were exceeded in 13 countries. Although these patterns could partly be a result of changes in disease transmission during the study period, it could also reflect a lost opportunity to strengthen and reinforce prudent antibiotic use.
我们观察到，2021 年和 2022 年期间，欧盟/欧洲经济区社区部门全身用抗菌药物（ATC J01）的消费出现反弹，此前 2019 年至 2020 年期间出现下降。2022 年的这一比率恢复到 COVID-19 大流行前的水平，有 13 个国家超过了这一水平。尽管这些模式可能部分是研究期间疾病传播变化的结果，但也可能反映出加强和强化谨慎使用抗生素的机会丧失。
Zotero 插件